A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

NCT00327015 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1306

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes

Interventions

DRUG: Saxagliptin
DRUG: Saxagliptin
DRUG: Metformin
DRUG: Placebo
DRUG: pioglitazone

Sponsor

AstraZeneca